Skip to main content

Table 3 Linear regression models to demonstrate associations between clinical and flow cytometry derived cell populations and hsCRP as biomarker for CVD risk

From: Immune cell phenotyping in low blood volumes for assessment of cardiovascular disease risk, development, and progression: a pilot study

 

FRS

β-coefficient (p-value)

hsCRP (mg/l)

β-coefficient (p-value)

Unadjusted

Adj. for BMI

Unadjusted

Adj. for BMI/age

Clinical neutrophil population (%)

0.49 (0.03)

0.49 (0.04)

− 0.08 (0.73)

− 0.06 (0.79)

FCD neutrophil population (%)

0.46 (0.04)

0.49 (0.04)

0.08 (0.73)

− 0.04 (0.87)

Clinical eosinophil population (%)

− 0.05 (0.84)

− 0.05 (0.85)

− 0.04 (0.88)

0.16 (0.50)

FCD eosinophil population (%)

0.22 (0.36)

0.22 (0.36)

− 0.19 (0.43)

− 0.13 (0.58)

Clinical basophil population (%)

0.36 (0.12)

0.36 (0.14)

− 0.13 (0.59)

− 0.16 (0.49)

FCD basophil population (%)

0.20 (0.39)

0.21 (0.39)

− 0.24 (0.31)

− 0.18 (0.45)

Clinical monocyte population (%)

0.38 (0.097)

0.38 (0.11)

− 0.35 (0.13)

− 0.37 (0.10)

FCD monocyte population (%)

− 0.20 (0.40)

− 0.20 (0.42)

− 0.36 (0.12)

− 0.32 (0.15)

Clinical lymphocyte population (%)

− 0.53 (0.02)

− 0.55 (0.02)

0.18 (0.45)

0.10 (0.66)

FCD T cell population (%)

− 0.47 (0.04)

− 0.47 (0.04)

0.10 (0.68)

0.14 (0.57)

FCD B cell population (%)

− 0.196 (0.41)

− 0.20 (0.42)

0.18 (0.44)

0.35 (0.18)

FCD NK cell population (%)

− 0.085 (0.72)

− 0.09 (0.72)

− 0.07 (0.77)

− 0.15 (0.52)

FCD NKT cell population (%)

− 0.020 (0.93)

− 0.02 (0.94)

0.22 (0.27)

0.28 (0.20)

FCD cell-platelet aggregate (PA)

 Neutrophils-PA

0.18 (0.45)

0.21 (0.44)

0.58 (0.01)

0.49 (0.04)

 Eosinophils-PA

0.20 (0.39)

0.22 (0.39)

0.58 (0.01)

0.49 (0.03)

 Basophils-PA

0.13 (0.58)

0.13 (0.60)

0.22 (0.36)

0.17 (0.46)

 T cells-PA

0.45 (0.05)

0.59 (0.03)

0.52 (0.02)

0.41 (0.11)

 B cells-PA

0.27 (0.24)

0.35 (0.20)

0.46 (0.04)

0.31 (0.21)

 NK cells-PA

0.44 (0.05)

0.55 (0.03)

0.55 (0.01)

0.45 (0.07)

 NKT cells-PA

0.43 (0.06)

0.53 (0.04)

0.45 (0.04)

0.32 (0.20)

 All monocyte-PA

0.24 (0.32)

0.24 (0.33)

0.23 (0.33)

0.19 (0.39)

 Classical monocyte-PA

0.19 (0.42)

0.19 (0.43)

0.22 (0.34)

0.19 (0.39)

 Intermediate monocyte-PA

0.18 (0.44)

0.18 (0.46)

0.23 (0.34)

0.23 (0.32)

 Nonclassical monocyte-PA

0.52 (0.02)

0.54 (0.02)

0.28 (0.23)

0.20 (0.40)

  1. Unadjusted and adjusted regressions (for age and BMI) were performed between the indicated parameters for African American women (N = 20) at increased risk for CVD. Each regression is given as β-coefficient with the p-value in parenthesis
  2. Significant associations are italicized
  3. FCD flow cytometry derived